Eaton Vance Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $83.5M | Buy |
471,626
+6,552
| +1% | +$1.29M | 0.12% | 167 |
|
|
2022
Q2 | $95.2M | Sell |
465,074
-16,269
| -3% | -$3.45M | 0.13% | 160 |
|
|
2022
Q1 | $114M | Buy |
481,343
+82,980
| +21% | +$19.5M | 0.13% | 153 |
|
|
2021
Q4 | $91M | Buy |
398,363
+99,452
| +33% | +$21.9M | 0.11% | 186 |
|
|
2021
Q3 | $56.8M | Buy |
298,911
+17,757
| +6% | +$3.6M | 0.08% | 241 |
|
|
2021
Q2 | $59.8M | Buy |
281,154
+11,147
| +4% | +$2.35M | 0.08% | 238 |
|
|
2021
Q1 | $55.1M | Sell |
270,007
-82,048
| -23% | -$16.2M | 0.08% | 234 |
|
|
2020
Q4 | $64.1M | Buy |
352,055
+82,270
| +30% | +$14M | 0.1% | 197 |
|
|
2020
Q3 | $45.1M | Sell |
269,785
-7,993
| -3% | -$1.35M | 0.08% | 226 |
|
|
2020
Q2 | $45.1M | Buy |
277,778
+12,675
| +5% | +$2.27M | 0.09% | 202 |
|
|
2020
Q1 | $45.8M | Sell |
265,103
-93,431
| -26% | -$18.6M | 0.11% | 176 |
|
|
2019
Q4 | $72M | Buy |
358,534
+10,455
| +3% | +$2.14M | 0.14% | 147 |
|
|
2019
Q3 | $73.6M | Sell |
348,079
-1,385
| -0.4% | -$289K | 0.16% | 143 |
|
|
2019
Q2 | $67.8M | Buy |
349,464
+21,764
| +7% | +$4.01M | 0.15% | 149 |
|
|
2019
Q1 | $53.9M | Buy |
327,700
+8,125
| +3% | +$1.44M | 0.12% | 168 |
|
|
2018
Q4 | $60.1M | Buy |
319,575
+3,215
| +1% | +$594K | 0.16% | 142 |
|
|
2018
Q3 | $53.8M | Sell |
316,360
-1,297
| -0.4% | -$218K | 0.12% | 173 |
|
|
2018
Q2 | $52.1M | Sell |
317,657
-307,843
| -49% | -$50.3M | 0.12% | 171 |
|
|
2018
Q1 | $101M | Buy |
625,500
+186,811
| +43% | +$29.7M | 0.13% | 170 |
|
|
2017
Q4 | $64.1M | Buy |
438,689
+146,279
| +50% | +$20.8M | 0.16% | 149 |
|
|
2017
Q3 | $39.7M | Buy |
292,410
+18,910
| +7% | +$2.39M | 0.1% | 184 |
|
|
2017
Q2 | $34.3M | Buy |
273,500
+3,859
| +1% | +$462K | 0.09% | 201 |
|
|
2017
Q1 | $32M | Buy |
269,641
+16,379
| +6% | +$1.97M | 0.09% | 202 |
|
|
2016
Q4 | $29.2M | Buy |
253,262
+19,000
| +8% | +$2.11M | 0.08% | 191 |
|
|
2016
Q3 | $24.5M | Buy |
234,262
+70
| +0% | +$7.31K | 0.07% | 202 |
|
|
2016
Q2 | $22.8M | Sell |
234,192
-17,551
| -7% | -$1.66M | 0.07% | 203 |
|
|
2016
Q1 | $24.2M | Buy |
251,743
+32
| +0% | +$2.91K | 0.07% | 200 |
|
|
2015
Q4 | $22.8M | Sell |
251,711
-2
| -0% | -$188 | 0.07% | 204 |
|
|
2015
Q3 | $23.3M | Buy |
251,713
+16,042
| +7% | +$1.52M | 0.07% | 203 |
|
|
2015
Q2 | $21.9M | Buy |
235,671
+17,854
| +8% | +$1.67M | 0.07% | 219 |
|
|
2015
Q1 | $20.6M | Buy |
217,817
+9,214
| +4% | +$854K | 0.06% | 226 |
|
|
2014
Q4 | $18.5M | Buy |
208,603
+2,315
| +1% | +$196K | 0.05% | 243 |
|
|
2014
Q3 | $16.5M | Buy |
206,288
+12,347
| +6% | +$930K | 0.05% | 244 |
|
|
2014
Q2 | $13.8M | Buy |
193,941
+88,518
| +84% | +$6.23M | 0.04% | 267 |
|
|
2014
Q1 | $7.8M | Buy |
105,423
+143
| +0.1% | +$10.8K | 0.02% | 329 |
|
|
2013
Q4 | $8.26M | Buy |
105,280
+2
| +0% | +$157 | 0.02% | 325 |
|
|
2013
Q3 | $7.78M | Buy |
105,278
+6
| +0% | +$442 | 0.02% | 318 |
|
|
2013
Q2 | $8M | Buy |
+105,272
| New | +$6.91M | 0.02% | 294 |
|
Other funds holding CME
Eaton Vance Management's CME Position: Q3 2022 in Review
Eaton Vance Management increased its CME Group (CME) stake by 1.4% in Q3 2022, buying an estimated $1.29M and bringing the position to 471,626 shares worth $83.5M. The position accounts for 0.12% of the portfolio, ranked #167.
Eaton Vance Management first reported a position in CME in Q2 2013 and has held it in 38 quarters since. The position peaked at $114M in Q1 2022. 1,145 funds tracked by Wall St. Rank hold CME as of Q3 2022.
- Eaton Vance Management held 471,626 shares of CME Group worth $83.5M as of Q3 2022.
- Eaton Vance Management bought 6,552 CME Group shares in Q3 2022, an estimated $1.29M.
- CME Group made up 0.12% of Eaton Vance Management's portfolio in Q3 2022, its #167 holding.
- Eaton Vance Management first reported a position in CME Group in Q2 2013 and has held it in 38 quarters since.
- Eaton Vance Management's CME Group position peaked at $114M in Q1 2022.
- 1,145 funds tracked by Wall St. Rank held CME Group as of Q3 2022.
Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.